The Research-Clinical Center for Cardiac Surgery and Transplantology LLP Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2020
NCT04325594
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

The Research-Clinical Center for Cardiac Surgery and Transplantology LLP

Active Ingredients

Drugs in Phase 2 Trials (1)

umbilical cord mesenchymal stem cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiomyopathies (Phase 2)

Cardiomyopathy, Dilated (Phase 2)

Heart Failure (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1